PharmaShots | Incisive News in 3 Shots

Subscribe Now

acquired thrombotic thrombocytopenic purpura (aTTP)

Sanofi's Cablivi Receives EU Marketing Approval for the Treatment of Acquired Thrombotic Thrombocytopenic Purpura (aTTP)

Sanofi's Cablivi Receives EU Marketing Approval for the Treatment of Acquired Thrombotic Thrombocytopenic Purpura (aTTP)

September 3, 2018

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us